Literature DB >> 1273214

Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects-a review.

J M Smith, H Misiak.   

Abstract

This literature review presents summary methodological and statistical data on 33 studies in which critical flicker frequency (CFF) thresholds were used to evaluate the effects of acute oral doses of single psychotropic drugs in normal human subjects. In all, 96 drug-dose-study combinations are represented. CFF was found to be altered to a statistically significant degree (P is less than 0.05) in 51 (65%) of the 79 instances in which inferential statistical methods were used to evaluate the results. As expected, stimulants increased CFF while hypnotics decreased it. There is also a discussion of important methodological considerations in the design of psychopharmacological studies employing CFF. While many studies have shown CFF to be sensitive to the effects of psychotropic drugs, there have not always been adequate controls for extraneous factors (especially, set and suggestion, changes in pupillary diameter, and the presence of other commonly used drugs). Finally, consideration is given to the attempts to increase the sensitivity of the CFF test to drug effects.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1273214     DOI: 10.1007/BF00735818

Source DB:  PubMed          Journal:  Psychopharmacologia


  49 in total

1.  Drugs and personality. VII. The effects of stimulant and depressant drugs upon pupillary reactions.

Authors:  H J EYSENCK; J A EASTERBROOK
Journal:  J Ment Sci       Date:  1960-07

2.  Alterations in critical flicker frequency as a function of age and light: dark ratio.

Authors:  R A McFARLAND; A B WARREN; C KARIS
Journal:  J Exp Psychol       Date:  1958-12

3.  The effects of autonomic drugs on human flicker discrimination.

Authors:  M ALPERN; R S JAMPEL
Journal:  Am J Ophthalmol       Date:  1959-01       Impact factor: 5.258

4.  Differential screening of phrenotropic agents in man: psychophysiologio test data.

Authors:  H E LEHMANN; J CSANK
Journal:  J Clin Exp Psychopathol       Date:  1957 Jul-Sep

5.  A comparison of two kinds of flicker phenomena as indicators of CNS involvement.

Authors:  F L McGUIRE
Journal:  J Nerv Ment Dis       Date:  1958-06       Impact factor: 2.254

6.  Continued meprobamate and proclorperazine administration and behavior.

Authors:  E L KELLY; J G MILLER; D G MARQUIS; R W GERARD; L UHR
Journal:  AMA Arch Neurol Psychiatry       Date:  1958-08

7.  Flicker-fusion in chronic barbiturate usage; a quantitative study in the pathophysiology of drug addiction.

Authors:  C M IDESTROM
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1954

8.  Determinants of the critical flicker-fusion threshold.

Authors:  C LANDIS
Journal:  Physiol Rev       Date:  1954-04       Impact factor: 37.312

9.  The effect of certain physiological determinants on the flicker-fusion threshold.

Authors:  C LANDIS; V HAMWI
Journal:  J Appl Physiol       Date:  1954-03       Impact factor: 3.531

10.  Flicker fusion frequency; background and applications.

Authors:  E SIMONSON; J BROZEK
Journal:  Physiol Rev       Date:  1952-07       Impact factor: 37.312

View more
  63 in total

1.  Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus.

Authors:  R H Hou; E R Samuels; M Raisi; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-11-25       Impact factor: 4.530

2.  A placebo-controlled study of effects of oral progesterone on performance and mood.

Authors:  E W Freeman; L Weinstock; K Rickels; S J Sondheimer; C Coutifaris
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

3.  Relationship between sedation and pupillary function: comparison of diazepam and diphenhydramine.

Authors:  Ruihua H Hou; Jessica Scaife; Clare Freeman; Rob W Langley; Elemer Szabadi; Chris M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

4.  A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.

Authors:  Ian Hindmarch; Eric Legangneux; Neil Stanley; Steve Emegbo; Jean Dawson
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

5.  Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses.

Authors:  K Aranko; T Seppälä; J Pellinen; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Comparison of pramipexole with and without domperidone co-administration on alertness, autonomic, and endocrine functions in healthy volunteers.

Authors:  Ebony R Samuels; Ruihua H Hou; Robert W Langley; Elemer Szabadi; Christopher M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

7.  First-in-human study with ACT-539313, a novel selective orexin-1 receptor antagonist.

Authors:  Priska Kaufmann; Marion Ort; Georg Golor; Rüdiger Kornberger; Jasper Dingemanse
Journal:  Br J Clin Pharmacol       Date:  2020-03-06       Impact factor: 4.335

8.  Nomifensine, clobazam and HOE 8476: effects on aspects of psychomotor performance and cognitive ability.

Authors:  A C Parrott; I Hindmarch; P D Stonier
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

9.  Inert gas narcosis in scuba diving, different gases different reactions.

Authors:  Monica Rocco; P Pelaia; P Di Benedetto; G Conte; L Maggi; S Fiorelli; M Mercieri; C Balestra; R A De Blasi
Journal:  Eur J Appl Physiol       Date:  2018-10-22       Impact factor: 3.078

10.  Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep.

Authors:  T Seppälä; E Nuotto; K Korttila
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.